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Abstract: The economic evaluation of health system interventions is challenging, and methods
guidance on how to respond to these challenges is lacking. The REACHOUT consortium developed
and evaluated complex interventions for community health program quality improvement in six
countries in Africa and Asia. Reflecting on the challenges we faced in conducting an economic
evaluation alongside REACHOUT, we developed a Structured Economic Evaluation Process for
Complex Health System Interventions (SEEP-CI). The SEEP-CI aims to establish the threshold
effect size that would justify investment in a complex intervention, and provide an assessment to a
decision-maker of how likely it is that the intervention can achieve this impact. We illustrate how the
SEEP-CI could have been applied to REACHOUT to identify outcomes where the intervention might
have impact and causal mechanisms, through which that impact might occur, guide data collection by
focusing on proximal outcomes most likely to illustrate the effectiveness of the intervention, identify
the size of health gain required to justify investment in the intervention, and indicate the assumptions
required to accept that such health gains are credible. Further research is required to determine the
feasibility and acceptability of the SEEP-CI, and the contexts in which it could be used.
Keywords: complex intervention; economic evaluation; health system interventions
1. Introduction
The Lancet Global Health Commission on High Quality Health Systems in the Sustainable
Development Goal era highlights the enormous scope for improving health through investment in
health systems, and the need for such investment to be efficient [1]. Economic evaluations of complex
health system interventions (e.g., providing training, creating a clinic or health facility, or increasing
staff numbers) are required to support this goal. However, in our experience, economic evaluations
are disproportionately skewed toward evaluating health technologies (e.g., a medicine, a device, or a
clinical management approach) rather than health system interventions. This bias towards economic
evaluation of health technologies over health system interventions can be seen in the UK, for example,
where the National Institute for Health and Care Excellence has a process for health technology
appraisals [2], but does not have an equivalent for health system interventions.
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It is likely that insufficient economic evaluations of health system interventions exist because
they are challenging to conduct, rather than because they are not needed. While guidance exists
on the development and evaluation of RCTs for complex interventions [3] and on the evaluation of
complex public health interventions [4], such guidance pays little attention to economic evaluation [5].
There are no such guidelines for economic evaluation of health system interventions, in contrast to
health technologies [6]. There is growing interest in developing and consolidating methods for the
economic evaluation of health system interventions, reflected in several methodological and editorial
publications in the recent literature [7–9].
We present here a case study involving a complex health system intervention from the REACHOUT
consortium [10], implementing quality improvement (QI) approaches with community health workers
(CHWs) in six countries. We use this case study to illustrate the challenges that can arise in determining
whether such interventions are cost-effective, and outline a Structured Economic Evaluation Process for
Complex Health System Interventions (SEEP-CI), which we developed in response to these challenges.
We use the case study to show how the SEEP-CI combines robust empirical evidence with analysis that
makes explicit what decision-makers would need to assume to justify implementing the intervention.
We discuss how SEEP-CI could provide an efficient approach to generating useful information for
decision-makers, particularly in lower- and middle-income countries (LMICs).
2. Materials and Methods—Development and Outline of the SEEP-CI
2.1. Description of Case Study
Community health programs (CHPs) in LMICs rely heavily on CHWs given the shortages of
professional health workers. CHWs provide services such as health education, counselling, screening,
diagnostics, and treatment. REACHOUT was a program of research motivated by the belief that
investing in quality improvement (QI) for CHWs, and CHPs more generally, could lead to substantial
and cost-effective health gains across the many disease areas that they address, by improving their
effectiveness in providing the services listed above. REACHOUT developed a suite of QI interventions
and explored their impact in six countries in Africa and Asia. CHW supervisors were trained in
supportive supervision techniques. Local community QI teams consisting of facility and community
stakeholders were trained in QI concepts and supported in using community health data to identify
problems and develop and implement appropriate solutions. The teams were not required to work on
any specific health area or issue due to differences in context and the local nature of community health,
though most dealt with broad areas of maternal and child health. Further details of the specifics of the
intervention can be found elsewhere [10,11].
2.2. Description of Challenges for the Economic Evaluation of Complex Health System Interventions Such
as REACHOUT
Health system interventions, by their nature, are inevitably complex. Complex interventions have
characteristics that create challenges for evaluation. Guidance on evaluating complex interventions
highlights these challenges, including ‘the difficulty of standardising the design and delivery of the
interventions, their sensitivity to features of the local context, nd the length and complexity of the
causal chains linking intervention with outcome’ [12]. There are specific challenges that arise when the
goal is an economic evaluation of a complex health system intervention, as Barasa et al. demonstrate
for the package of care interventions [13]. The REACHOUT suite of interventions clearly featured
these challenges, and we illustrate below how this created difficulty for an economic evaluation of
these interventions.
2.2.1. Dispersed Impacts
CHWs influence numerous process and health outcomes, depending on the organization of the
health system they interact with, and the prevalent health issues in the populations that they serve, as
Int. J. Environ. Res. Public Health 2020, 17, 6780 3 of 12
well as one-off health challenges, such as pandemics, that can be unpredictable. This made it difficult to
design data collection on the benefits of the REACHOUT QI interventions. A further concern, similar
to that identified for patient safety interventions [14], was that the impact of QI interventions might
comprise a large number of small benefits across diverse patient groups, making it difficult to establish
whether the overall impact was large enough to make interventions cost-effective.
2.2.2. Non-Standardized Interventions
REACHOUT involved a suite of complex interventions that were iterated over time to improve
their effectiveness. While there was an overarching consistency across their implementation from the
study design, those who implemented the interventions inevitably did so in ways that could not be
fully specified in the protocol, and varied between countries. For example, local QI teams were free to
develop and implement changes that they saw as priorities, and these initiatives inevitably varied
across countries, as they were operating in different contexts, and faced different resource constraints.
Some QI teams focused on training, for example, while others identified routine data reporting as
a priority.
2.2.3. Complex Causal Relationship between Intervention and Outcome
REACHOUT interventions were targeted at improving outcomes such as referral rates, or how
often CHWs identified red flag symptoms correctly. These were intended to lead to health gains, for
example, through earlier presentation, leading to reduced risk of complications and better outcomes, but
the complex causal chain between action and health allowed for substantial potential for confounding,
through factors such as disease outbreaks, economic hardship, or political change. Essentially, the
arms-length relationship between intervention and health effect created a ‘signal-vs.-noise’ problem.
2.2.4. Impact Conditional on Health System Functioning
The impact of Community Health QI depended on the health system in which CHWs worked.
REACHOUT might have succeeded in improving CHW skills and motivation, and this might have
led to higher numbers of appropriate referrals, but the health system might then have lacked the
ability or resources needed to provide adequate care for those referred, due to issues such as lack
of medicines, unwelcoming staff at the facility of reference, or numerous other demand or supply
constraints that apply in LMIC settings [15]. In that case, the intervention would appear to have failed,
despite its achievements.
3. Results—Development of the SEEP-CI and Illustrative Application to an Evaluation of
Embedding QI in Community Health Programs
3.1. Development of the SEEP-CI
The conventional approach to gathering the evidence required would be to conduct a randomized
controlled trial (RCT), in which the primary outcome(s) would be relevant to the decision being
informed. The combined impact of the challenges described above is that, for such a study to be
definitive, the sample size would need to be unfeasibly large. We propose an alternative approach
that aims not to establish a precise estimate of the costs and benefits associated with the health
system intervention, but instead asks ‘how plausible is it that the intervention is worth investing
in’? This approach blends the strengths of RCT design with a structure drawing on formal decision
theory [16] that allows policymakers to exercise judgement in interpreting available evidence to
determine investment priorities.
The SEEP-CI evolved over several years during the REACHOUT project. Its development was
informed by discussions with consortium researchers and other stakeholders, such as national and
district level health workers and officials, in each of the participating countries. That process involved
identifying the challenges described above and eliciting qualitative data from policymakers on what
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they perceived to be the uses and shortcomings of conventional economic evaluations [17]. While
those discussions were helpful in identifying the shortcomings of conventional economic evaluation
approaches for decision-making, the SEEP-CI was developed by the authors with no formal input
from external experts, thus no formal procedure for reaching consensus about the steps involved (e.g.,
the DELPHI method [18]) was conducted or required, and the steps of the SEEP-CI, described below,
solely reflect the views of the authors.
3.2. Description of the SEEP-CI
The SEEP-CI comprises the following six steps.
3.2.1. Identify and Categorize Outcomes of the Intervention
We use the term ‘outcome’ to mean anything that might change, directly or indirectly, if an
intervention were implemented. For health technologies, key health outcomes can often be easily
identified. Health system interventions are likely to have more wide-ranging and diverse outcomes,
given their complexity and impact on multiple clinical and health system pathways, and process
outcomes can be as informative as health outcomes. The first step in the SEEP-CI is therefore to identify,
as comprehensively as possible, all the outcomes that might be affected by the intervention. To aid this
process, we suggest categorizing outcomes along two dimensions:
Intrinsic vs. Instrumental—Intrinsic outcomes are those that stakeholders value for their own
sake, such as mortality or cases of disease averted. Instrumental outcomes are those that are not valued
in their own right, but generate value by influencing intrinsic outcomes, such as blood pressure levels
or staffing ratios.
Proximal Vs. Distal—Proximal outcomes are those directly affected by an intervention, such as
the number of staff who have received training. Distal outcomes are those where there is a multi-link
causal chain linking the outcome to the intervention, such as the mortality rate for a given condition in
a population of interest.
Whether an outcome is instrumental or intrinsic may depend on the perspective of the stakeholder
(and some may be both), and the distinction between proximal and distal is one of degree. However, the
purpose of this classification is to deepen understanding of potential mechanisms through which the
intervention might effect change, and recognize, as broadly as possible, where the intervention might
create value. Therefore, the process of identifying and categorizing outcomes, and the discussions
involved in doing so, are of greater importance than the category to which outcomes are assigned.
Moreover, the relevance of an outcome will depend on the decision perspective. Our examples are
health-related, but outcomes beyond health should also be considered at this step if they are likely to
be of importance to the decision-maker.
3.2.2. Develop a Conceptual Model Outlining the Causal Relationship between the Intervention and
the Outcomes Identified in Step One
A conceptual model is a representation of a system that describes its elements and the causal
relationships between them [19]. The aim of developing such a model is to identify the mechanisms
through which the intervention might generate impact. With health system interventions, there is
likely to be a complex causal network linking outcomes, with feedback loops reinforcing or attenuating
impacts. The aim of constructing the conceptual model is to capture, share and refine an understanding
of what the effects of the intervention are, how they ripple through the complex system in which they
act, how feedback loops might reinforce or counter effects, and where potential for confounding exists.
To construct such a model, it will be necessary to:
(i) understand what the proximal goal of the intervention is, such as delivering a training package to
a specific cadre of health workers
(ii) specify the relationship between this goal and health care delivery e.g., better trained workers
might miss fewer cases where referral to specialists was required
Int. J. Environ. Res. Public Health 2020, 17, 6780 5 of 12
(iii) determine the consequences of changing health delivery e.g., whether more appropriate referrals
might improve survival rates
(iv) identify potential feedback loops e.g., improved survival might increase patient willingness
to engage with the health system, leading to more opportunities for health workers to learn
through experience
Identifying all these causal links will require input from all stakeholders—health workers,
managerial staff, patient groups—and formal processes exist to facilitate this [20]. Going through this
process of identification is likely to suggest additional outcomes not included in Step One. Therefore,
Steps One and Two are best conducted iteratively. Identifying outcomes will prompt stakeholders to
think of plausible mechanisms linking them and identifying mechanisms will lead to further outcomes
of interest being identified.
3.2.3. Identify Key Intrinsic Outcomes that Will Drive the Adoption Decision
Step One will have identified numerous intrinsic outcomes across multiple clinical areas. We
recommend that the study team select a subset of these outcomes for evaluation, perhaps even as few
as one or two. The intrinsic outcomes selected should be ‘decision drivers’ i.e., those thought to be most
influential in determining whether an intervention is cost-effective. Decision drivers will be outcomes
where the intervention is likely to have the greatest total impact, and the evidence supporting that
impact is strongest. The size of achievable impact will be greater for commonly occurring events
with severe health consequences and/or high costs. The actual impact resulting from the intervention
can be estimated more precisely and convincingly when the causal chain linking intervention to
impact is short, and the links in that chain are strongly supported by evidence and expert knowledge.
This reduces the potential for confounding and the likely uncertainty around recommendations for
decision-makers. The rationale for this step is that it will usually not be feasible to capture the impact
of the intervention across all the outcomes identified in Step One, so, following the criteria described
here will ensure the efficient use of available study resources.
3.2.4. Estimate the Cost of Delivering the Intervention, and the Threshold Change in the Key Intrinsic
Outcome(s) Required for the Intervention to Be Cost-Effective
It will usually be possible to estimate and cost the resources required to implement an intervention,
based on the study protocol. If the decision-maker’s willingness to pay per unit gain in an intrinsic
outcome can be established, the change in that outcome required to justify the investment can be
calculated. For example, if a national training program for medical officers would cost 0.1 million USD,
and the national willingness-to-pay threshold is 1000 USD per DALY, then the training program would
need to result in 100 DALYs averted to justify investing in it.
The reason for focusing on the direct costs of implementing an intervention is that they are
key to understanding impact on constrained budgets and resources, and that they can be calculated
without requiring substantive assumptions about the knock-on impact on healthcare resource use.
If these knock-on impacts are important to the evaluation, it might be appropriate to expand the
threshold analysis to include them. For example, if the training program described above would
require additional investment in testing and treatment resources to yield health gains, then the target
for DALYs averted would rise by 1 DALY for each 1000 USD of investment required.
3.2.5. Identify Proximal Instrumental Outcomes that are Likely to Cause Changes in the Key Intrinsic
Outcome(s) Identified in Step Three, and Estimate the Effectiveness of the Intervention in Terms of
These Proximal Outcomes
The intrinsic outcome(s) selected in Step Three will have been chosen with the simplicity and
plausibility of the causal mechanism between outcome(s) and intervention in mind. Nevertheless,
that causal chain is likely to be indirect, making attribution difficult. What can be established is how
far the intervention is able to affect the proximal outcomes that it is designed to affect. The RCT is
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the gold standard study design and should be followed where possible to provide decision-makers
with credible information about the effectiveness of the intervention. We propose that the primary
outcome around which such a study is designed be chosen, based on the insights from Step Two, to
be proximal, instrumental, and on the causal chain to the intrinsic outcome identified in Step Three.
For example, if the intervention is a training program in ante natal care, the primary outcome for a
study evaluating the intervention should be the numbers attending training and/or the change in their
knowledge of red flags and appropriate referral routes, rather than neonatal outcomes. This does not
preclude collecting data on a distal intrinsic outcome such as neonatal health, but it protects against
the considerable risk of the study, failing to show a significant attributable impact of the intervention
on the distal intrinsic outcome, for all the reasons explored in Section 2. In this case, it should still
be possible to establish that the intervention has had an impact, albeit on the proximal instrumental
outcome. The resulting impact on the distal outcome of interest can then be inferred through analytical
approaches, then combine study results, the literature, and expert opinion, as per the next step.
3.2.6. Assess the Strength of the Case for Investing in the Intervention
The previous steps will provide decision-makers with robust estimates of the investment required
to implement a health system intervention, the size of the proximal impact it will have, and the
minimum health gains that this proximal impact should generate for investment to be worthwhile.
The remaining question is ‘how likely is it that the proximal impact generated by the intervention
will lead to greater health gains than this minimum’? This question will require judgement from the
decision-maker, as all the challenges described earlier apply here. However, there are analyses that can
be provided to the decision-maker to support their assessment. Decision-analytic modelling, drawing
on the conceptual model developed in Step Two, can illustrate the assumptions that need to be made
to arrive at the required threshold health gain from the proximal effectiveness of the intervention.
Evidence to support such assumptions can be sourced from the literature, or from expert opinion.
Considerable uncertainty may still remain around the level of health gains that the intervention might
generate for a given decision-maker, but the structured approach we described will provide them with
the support needed to decide whether the existing evidence is strong enough to justify investment in a
health system intervention, and, if not, where the key information gaps are.
Figure 1 sets out the steps involved in the SEEP-CI. If decision-makers take a view that the findings
from the SEEP-CI are not sufficiently convincing for them to invest in the health system intervention,
this may be because the selection of outcomes at Step Three was too narrow. The conceptual model
from Step Two can be used to elicit decision-maker views on whether additional intrinsic outcomes
should be added to the analysis and, if so, which ones. This can then be included in a revised Step
Six analysis, for example, by additional decision-analytic modelling, to explore the sensitivity of
cost-effectiveness to including additional benefits.Int. J. Environ. Res. Public Health 2020, 17, x FOR PEER REVIEW 7 of 12 
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3.3. Application of the SEEP-CI to Evaluation of Embedding QI in Community Health Programmes
The SEEP-CI was developed from evaluative research carried out during REACHOUT, rather than
the other way around. However, we can still illustrate how we might have structured that research if
an economic evaluation of REACHOUT had been based on the SEEP-CI.
3.3.1. Identify and Categorize Outcomes
Annual meetings held to bring together members of the consortium gave us opportunities for an
in-depth discussion about what might change because of the intervention. We then invited consortium
members to apply the intrinsic vs. instrumental and proximal vs. distal categorization described
above. Table 1 gives some of the results of this process. Consortium members were able to identify
several outcomes where the impact of community-level QI might be observed. Their wide-ranging
role in community health means that a range of specific health outcomes (e.g., maternal mortality,
diarrhea-related deaths) could be included as distal intrinsic outcomes, and that a generic health
measure (e.g., DALYs) might also be appropriate. Country-level research teams identified several
measures that would be proximally affected by REACHOUT interventions, most of which were
instrumental. The investment required to conduct training and hold QI meetings was an obvious
intrinsic proximal outcome. Additionally, it was thought plausible that staff wellbeing might directly
improve through the interventions.
Table 1. Outcomes impacted by REACHOUT, categorized as instrumental vs. intrinsic and proximal
vs. distal.
PROXIMAL DISTAL
INSTRUMENTAL
Supervisory support for CTC providers
CTC provider motivation
Number of quality improvement (QI) meetings
Number of QI initiatives proposed
Number of QI teams trained in the global curriculum
Utilization of health clinics
Community satisfaction with
CTC providers
CTC provider turnover
Uptake of vaccinations
INTRINSIC Costs of trainingStaff wellbeing
Maternal mortality
DALYs
Deaths due to diarrhea
3.3.2. Develop a Conceptual Model of Causal Links between Outcomes
REACHOUT included several linked but discrete interventions. In Figure 2, we present a
conceptual model for one of them—training supervisors in supportive approaches to CHWs. The
conceptual model came out of a guided workshop held in Nairobi, Kenya in April 2018, attended
by REACHOUT health systems researchers from four participating countries. At the workshop,
country teams developed conceptual models based on their understanding of the role of CHWs in
their health systems. We integrated these models into the version presented in Figure 2, drawing on
additional insights from stakeholders. The combined model illustrates the complex causal network
propagating the proximal impacts of supportive supervisor training (more supportive and more
frequent supervision). It includes feedback loops such as increased motivation, leading to improved
quality of care, resulting in greater willingness by the community to use CHWs, further increasing
their motivation.
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3.3.4. Estimate the Costs of Delivering the Intervention, and the Threshold Change Required for the
Intervention to Be Cost-Effective
Given the challenges described above, we were unable to robustly estimate effects,
cost-effectiveness ratios, or net monetary benefit for REACHOUT. However, we were able to conduct a
detailed, country-specific exercise in costing the interventions evaluated, which has been reported
elsewhere [11]. The key parameter from that costing exercise was the cost per CHW of QI. We found
that the annualized cost of QI per CHW ranged from 62 USD (Mozambique) to 254 USD (Ethiopia).
A full assessment of the level of benefit required to justify this investment was beyond the scope of
the REACHOUT study. For illustrative purposes, assuming a marginal effectiveness of healthcare
investment of 1786 USD per DALY, which was the upper threshold estimated by Woods et al. for
Indonesia [21], the target DALYs gained per CTC provider would need to be 0.03 for an investment of
62 USD, or 0.14 for an investment of 254 USD.
3.3.5. Identify the Key Proximal Instrumental Outcomes for the Intervention, Estimate the
Effectiveness of the Intervention on these Outcomes, and Assess the Strength of the Case for Investing
in the Intervention
Given that the approach that we present was developed after the design of the REACHOUT
project, it was not possible to fully carry out the work required for these steps within REACHOUT.
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However, we can illustrate what work would be required, and how it might then be used. We base
this illustration on a published economic evaluation of a community-based intervention to improve
birth outcomes in rural Nepal [22]. Borghi et al. estimated that their intervention would lead to a 1%
absolute reduction in infant mortality, resulting in 921 life years gained per 100,000 people covered
by CHWs. We might assume that the impact of community-level QI would be mediated through
increased ability to deliver interventions, such as that developed by Borghi et al. The costing conducted
as part of REACHOUT found that the cost of community-level QI was between 1000 and 5000 USD
per 100,000 people covered. Therefore, if CTC provider QI enhanced the effectiveness of the Borghi et
al. intervention by 5%, this would result in 0.05 × 921 = 46 additional life years, giving a cost per life
year gained of 108 USD. If the effectiveness were increased by 50%, the additional life years gained
would rise to 460, and the cost per life year gained fall to 11 USD. For any given willingness-to-pay
to gain a life-year, the target level by which QI enhanced the intervention could thus be calculated.
REACHOUT documented how the CTC provider QI interventions impacted proximal measures such
as motivation and QI activity, and this evidence could be provided to the decision-maker to help them
assess how likely it was that the target gain in effectiveness would be met.
4. Discussion
The aim of the SEEP-CI is not to determine the impact or cost-effectiveness of a complex intervention
as completely, precisely, and robustly as possible. Instead, it seeks to establish the threshold effect size
that would justify investment in a complex intervention, and provide an assessment to a decision-maker
of how likely it is that the intervention can achieve this impact. This contrasts with conventional
evidence-based medicine perspectives that favor gold-standard evidence, such as RCTs. Our concern
is that it is inherently more challenging to provide such evidence for health system interventions than
health technologies. If the requirement for gold-standard evidence is applied inflexibility, this will lead
to underinvestment in health system interventions. Nevertheless, decision-makers still need rational,
evidence-based analysis to support such investment.
The SEEP-CI developed out of the difficulties that arose in attempting an economic evaluation
alongside REACHOUT. REACHOUT was motivated by the observation that CHWs are an integral
part of health care delivery in many LMICs, but there was limited investment in their training and
supervision, or other QI measures for community health. This led to a hypothesis that investing in
such measures could lead to substantial health gains at reasonable cost. While it was feasible to assess
costs, the health gains were much more challenging to capture precisely. The reasons, presented here,
are commonly found in health system interventions, and largely arise because we are intervening at a
system rather than a patient level. As a result, impacts are diffused across multiple clinical conditions,
with many causal steps between intervention and intrinsic outcome. Our view was that a case could
be made in support of the hypothesis, but not a conclusive one, and that decision-makers needed to
be presented with this case so that they could make an informed judgement. The SEEP-CI provides
decision-makers with this case.
The challenges that arise when evaluating complex interventions, and the problems this creates
for conducting RCTs, are well understood [23]. These challenges have led to the development of
approaches such as realist evaluation, which explicitly considers the mechanisms and context in which
an intervention acts [24], and has proven to be valuable for health systems research [25]. The SEEP-CI
is naturally complementary with realist evaluation, sharing its focus on going beyond empiricism to
consider mechanisms. It does differ from realist methodology in taking a decision-theoretic perspective
on research design. The key consequence to this perspective is the approach to uncertainty. Reframing
the question from ‘Does the intervention work’ to ‘Should a funder invest in it?’ leads to the recognition
that there are costs involved in reducing uncertainty, so that it may be optimal to invest in an
intervention, even if the evidence supporting it has limitations. We also draw on a body of decision
theory known as ‘Soft OR’ [26]. Soft OR provides methods for incorporating into decision analysis
aspects of a decision problem that are subjective and amenable to multiple perspectives. The use of
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conceptual models, the integration of a broad range of stakeholders and their perspectives into the
analysis, and the iterative application of steps to allow feedback from later steps to revise work from
earlier ones, are all aspects of the SEEP-CI that draw on insights from soft OR approaches such as
problem structuring methods [27] and soft systems methodology [28].
The SEEP-CI involves several potentially subjective choices, such as the selection of intrinsic
outcomes, the identification of links in the causal network, and the assessment of the strength of
the cause-effect relationship between proximal and distal outcomes. We overcome this possibility
of subjectivity in two ways. Firstly, we highlight the importance of establishing, objectively and
empirically, the effectiveness of the intervention in terms of key proximal outcomes. This should
be done using the most robust study design possible, ideally via an RCT, to provide the strongest
evidence possible of the proximal impact of the intervention. Secondly, the SEEP-CI separates what is
known from what is assumed, and explicitly sets out, via threshold analyses, the minimum that must
be assumed to justify investing in the intervention. The credibility of the analysis will be strengthened
by involving as wide a range of stakeholders as possible in each of the steps of the SEEP-CI. It is
the responsibility and the privilege of the decision-maker to determine whether the investment case
generated by the SEEP-CI is strong enough.
The SEEP-CI described here is an exploratory attempt to formalize an approach to the economic
evaluation of complex health system interventions. It is intended to enhance, rather than replace,
existing guidelines for the conduct and reporting of economic evaluations, such as those provided by
the ISPOR CHEERS Taskforce [29]. Such guidelines set out core principles for economic evaluation
that apply equally to health system interventions as health technologies, such as clearly defining the
intervention and the decision population, identifying an appropriate time horizon and discount rates,
providing sources for costs, and so on. We expect the SEEP-CI to be a helpful enhancement to existing
guidance for the economic evaluation of complex health system interventions, based on strengths
such as its focus on measuring proximal outcomes, creating and validating conceptual models, and
threshold analyses. We anticipate that it will be particularly valuable in LMIC settings, given the
logistical and resource challenges involved in conducting primary research in such settings. However,
we accept that there are limitations to the SEEP-CI currently that would need to be addressed before it
can be credibly used. We have yet to test the SEEP-CI by using it from the start of the study. Moreover,
the SEEP-CI is our proposed solution to the challenges of evaluating health system interventions,
rather than reflecting the input of multiple experts synthesized through a formal consensus process,
as was involved in developing guidelines such as CHEERS. Further research validating the SEEP-CI,
exploring its feasibility, acceptability to decision-makers, and ability to generate credible and helpful
results, is required. A formal task force would be particularly suitable to developing the SEEP-CI
further. We believe that this would be worthwhile if the approach proves to be valuable, and leads to
greater and more efficient investment in health system interventions, then the potential health gains
are substantial. Furthermore, while the approach we set out here focuses on allocative efficiency,
decision-makers are often interested in addressing health inequity as well as maximizing health gains.
Further development of the SEEP-CI could involve extending the approach to reflect this need, for
example by including subgroup analyses, or ensuring equity-based outcomes are formally included.
5. Conclusions
The SEEP-CI can assist decision-makers by separating out what is known from what must be
assumed, and by providing guidance about what criteria must be met to make investment in a complex
intervention worthwhile. The credibility of the analysis can be enhanced by explicitly involving as
broad a range of stakeholders as possible in each step, including the decision-maker. The SEEP-CI
can be used to highlight exactly which assumptions are most disputed, and assess how sensitive the
decision would be to these assumptions. It also allows decision-makers to take a conservative approach
by ‘raising the bar’ i.e., by raising the cost-effectiveness threshold applied to reflect the lesser quality
of the evidence. We hope that, through these measures, decision-makers will feel more comfortable
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making decisions around investing in complex health system interventions, and the overall efficiency
of health systems will improve substantially as a result.
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